Non-Formulary Drug Insurance Denied? How to Appeal

When your insurance company denies coverage for a drug that is not on its formulary, you are left facing either an unaffordable out-of-pocket cost or a switch to a medication your doctor did not recommend for you. Non-formulary drug denials are extremely common — and they are also among the most frequently reversed on appeal when patients and physicians document the clinical need properly.

Why Insurers Deny Non-Formulary Drug Claims

Drug not on the formulary. The most straightforward denial: your medication is not included on the insurer's approved drug list. Under ACA Section 1302(b)(1) and ERISA, plans must cover prescription drugs as an essential health benefit, but they have discretion over which specific drugs are included. However, if no formulary drug is adequate for your medical needs, you can request a formulary exception.

Step therapy requirements. Even for drugs on the formulary, insurers require patients to try and fail lower-tier drugs before approving higher-tier or specialty drugs. For many non-formulary drugs, step therapy means you must document failure of two or more formulary alternatives. Most states now have step therapy exception laws requiring insurers to grant exceptions within specific timeframes when clinical criteria are met — including when you have already tried the step drug, when it is contraindicated, or when step therapy would cause adverse clinical consequences.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization not obtained. Many drugs — especially specialty biologics, oncology agents, and newer brand-name medications — require prior authorization before dispensing. If the authorization was not obtained or was submitted without sufficient supporting documentation, the claim is denied. A properly documented prior authorization request with a physician letter is often sufficient to reverse this denial.

Experimental or investigational classification. Some newer drugs — particularly in oncology and rare disease treatment — may be denied as experimental even when FDA-approved. Off-label use of FDA-approved drugs is also sometimes denied as experimental. Under ERISA and state insurance laws, this classification can be challenged when the drug has clinical guideline support from organizations like NCCN, AHA, ADA, or specialty societies.

Quantity limit exceeded. Even formulary drugs may be denied when the prescribed quantity exceeds the plan's quantity limit. If the prescribed quantity is clinically necessary — for example, a higher dose or more frequent dosing than the standard — physician documentation of the medical basis for the prescribed quantity is required.

How to Appeal a Non-Formulary Drug Denial

Step 1: Request the Denial Details and Formulary Exception Process

Obtain the written denial identifying the specific reason — non-formulary status, step therapy, prior authorization failure, or experimental classification. Request the formulary exception or prior authorization exception process from your insurer. Under ERISA (29 CFR § 2560.503-1) and ACA regulations, this information must be provided. Also request the clinical policy bulletin or formulary tier criteria used in the denial.

Step 2: Obtain Your Physician's Letter of Medical Necessity

Your prescribing physician must write a detailed letter addressing: the diagnosis and medical necessity of the specific drug, why formulary alternatives are inappropriate (side effects, contraindications, prior failure, disease characteristics), clinical guideline support for the prescribed drug, and the expected clinical consequences of denying the medication. This letter is the most important document in any non-formulary appeal.

Step 3: Cite Clinical Guidelines Supporting the Prescribed Drug

Research published clinical guidelines from major medical organizations that support your prescribed drug for your diagnosis. NCCN guidelines for oncology drugs, ACC/AHA guidelines for cardiovascular medications, ADA Standards of Care for diabetes medications, and specialty society guidelines for rheumatology, neurology, and other conditions are authoritative sources. Cite these guidelines directly in your appeal, quoting specific language supporting the drug's use.

Step 4: Invoke Step Therapy Exception Rights

If step therapy is the denial reason, invoke your state's step therapy exception law. As of 2025, more than 30 states have enacted step therapy exception statutes. The exception typically must be granted when: the step drug was previously tried and failed or caused adverse effects; the step drug is contraindicated based on the patient's medical history; or clinical evidence demonstrates the step drug would be ineffective or harmful for the patient's specific condition. State laws typically require the insurer to act on a step therapy exception request within 72 hours for urgent cases and 14 days for standard cases.

Step 5: Submit the Formal Appeal with a Structured Letter

Your appeal letter must reference the claim number, denial date, and specific denial reason. Attach your physician's letter and the clinical guideline citations. For ERISA plans, cite 29 CFR § 2560.503-1 (right to full and fair review) and 29 U.S.C. § 1133 (notice requirements). Request a peer-to-peer review between your physician and the insurer's pharmacy director or medical director — this is particularly effective for specialty drug denials.

Step 6: External Independent Review: Complete Guide" class="auto-link">External Review and State Complaint

If the internal appeal fails, request external review under ACA Section 2719 or applicable state law. Non-formulary drug denials are eligible for external review when they involve medical necessity determinations. File a concurrent complaint with your state department of insurance if the insurer violated step therapy exception laws or failed to act within required timeframes.

What to Include in Your Appeal

• Denial letter with the specific formulary or authorization criteria cited
• Prescribing physician's letter explaining why non-formulary alternatives are medically inappropriate
• Clinical guideline citations from authoritative medical organizations supporting the prescribed drug
• Documentation of prior formulary drug failures or contraindications (if step therapy is the issue)
• State step therapy exception law citation if applicable to your situation

Fight Back With ClaimBack

Non-formulary drug denials based on step therapy requirements and medical necessity disputes are among the most frequently reversed insurance decisions when physicians document the clinical rationale properly and appeal letters cite the right clinical guidelines and legal authorities. ClaimBack generates a professional appeal letter in 3 minutes. Start your free claim analysis → Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal